Roles of αsynuclein in gastrointestinal microbiome dysbiosisrelated Parkinson's disease progression (Review).
Reads0
Chats0
TLDR
In this article, the abnormal accumulation of α-synuclein (α-syn) in the intestine caused by changes to the gastrointestinal microbiome (GM) caused misfolding and abnormal aggregation of α−syn in the intestines, leading to the formation of eosinophilic Lewis bodies in the cytoplasm and mitochondrial dysfunction in dopaminergic (DA) neurons.Abstract:
Parkinson's disease (PD) is the second most common neurodegenerative disease amongst the middle‑aged and elderly populations. Several studies have confirmed that the microbiota‑gut‑brain axis (MGBA) serves a key role in the pathogenesis of PD. Changes to the gastrointestinal microbiome (GM) cause misfolding and abnormal aggregation of α‑synuclein (α‑syn) in the intestine. Abnormal α‑syn is not eliminated via physiological mechanisms and is transported into the central nervous system (CNS) via the vagus nerve. The abnormal levels of α‑syn aggregate in the substantia nigra pars compacta, not only leading to the formation of eosinophilic Lewis Bodies in the cytoplasm and mitochondrial dysfunction in dopaminergic (DA) neurons, but also leading to the stimulation of an inflammatory response in the microglia. These pathological changes result in an increase in oxidative stress (OS), which triggers nerve cell apoptosis, a characteristic of PD. This increase in OS further oxidizes and intensifies abnormal aggregation of α‑syn, eventually forming a positive feedback loop. The present review discusses the abnormal accumulation of α‑syn in the intestine caused by the GM changes and the increased levels of α‑syn transport to the CNS via the MGBA, resulting in the loss of DA neurons and an increase in the inflammatory response of microglial cells in the brain of patients with PD. In addition, relevant clinical therapeutic strategies for improving the GM and reducing α‑syn accumulation to relieve the symptoms and progression of PD are described.read more
Citations
More filters
Journal ArticleDOI
Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
TL;DR: The hypothesis that Parkinson’s disease could begin in the gut is supported, with a focus on how food-based therapies might then have an influence on PD and could ameliorate non-motor as well as motor symptoms.
Journal ArticleDOI
Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis
Júlio César Claudino dos Santos,Micael Porto Portela Lima,Gerly Anne de Castro Brito,Glauce Socorro de Barros Viana +3 more
TL;DR: In this article , the authors discuss how the microbiota-gut-brain axis and environmental influences interact with the immune system to promote a pro-inflammatory state that is involved in the initiation and progression of misfolded α-synuclein proteins and the beginning of the early non-motor symptoms of Parkinson's disease.
Journal ArticleDOI
Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease
Tiantian Li,Chuanqi Chu,Leilei Yu,Qixiao Zhai,Shunhe Wang,Jianxin Zhao,Hao Zhang,Wei Jiong Chen,Fengwei Tian +8 more
TL;DR: In this paper , the effects of probiotic Bifidobacterium breve CCFM1067, administered for 5 weeks in a Parkinson's disease (PD) mouse model, were examined.
Journal ArticleDOI
Bacillus amyloliquifaciens-Supplemented Camel Milk Suppresses Neuroinflammation of Autoimmune Encephalomyelitis in a Mouse Model by Regulating Inflammatory Markers
TL;DR: In this paper , Bacillus amyloliquefaciens-supplemented camel milk (BASY) was used to assess its preventive effect on MS symptoms in a myelin oligodendrocyte glycoprotein (MOG)-immunized C57BL6J mice model.
Journal ArticleDOI
METTL14 is decreased and regulates m6A modification of α‐synuclein in Parkinson's disease
Honghu He,Qinxin Zhang,Jiajia Liao,Jiang Lei,Man Luo,Jian-feng Huang,Mei-Ling Chen,Yuefei Shen,Jing Wang,Pingyi Xu,Yousheng Xiao +10 more
TL;DR: In this article , the role of m6A modification and its underlying mechanism in Parkinson's disease was investigated and the potential of METTL14 as a novel diagnostic biomarker for PD was revealed.
References
More filters
Journal ArticleDOI
Lipid metabolism alterations in the neuronal response to A53T α-synuclein and Fe-induced injury.
Sofía Sánchez Campos,Natalia Paola Alza,Gabriela Alejandra Salvador,Gabriela Alejandra Salvador +3 more
TL;DR: Evidence is reported of a differential role played by A53T α-syn in neuronal lipid metabolism as related to the neuronal response to OS and whether lipid metabolism has implications for neuronal fate.
Journal ArticleDOI
Gut-Brain axis in Parkinson's disease etiology: The role of lipopolysaccharide
TL;DR: The present review will focus on the intermolecular interactions of α-syn with bacterial lipid components, particularly LPS, with a definite clinical manifestation in PD pathogenesis, and should prompt the correlation of potential risk of amyloidogenesis upon detection of specific paradigm shifts in the microbial composition of the gut.
Journal ArticleDOI
Unravelling the role of gut microbiota in Parkinson’s disease progression: Pathogenic and therapeutic implications
Linchi Rani,Amal Chandra Mondal +1 more
TL;DR: A review of the role of the gut microbiota in the initiation, progression, and current therapeutic intervention to deplete the severity of Parkinson's disease is presented in this paper, which raises the intriguing question - how gut microbial dysbiosis could contribute to PD progression.
Journal ArticleDOI
Beyond here be dragons: SIBO in Parkinson's disease.
TL;DR: The investigators went on to show that the presence of SIBO in individuals with PD may have important consequences, not only in the form of GI symptoms but also with regard to motor function in that individuals with SIBO experienced more severe motor fluctuations, particularly of the “delayed-on” and dose failure type.
Journal ArticleDOI
Association of Parkinson's Disease With Microbes and Microbiological Therapy.
Zhao-Ji Chen,Cheng-Yu Liang,Li-Qing Yang,Si-Min Ren,Yan-Min Xia,Lei Cui,Xiao-Fang Li,Bu-Lang Gao +7 more
TL;DR: Parkinson's disease (PD) is the most common movement disorder in the world, affecting 1-2 per 1,000 of the population as discussed by the authors, and the main pathological changes of PD are damage of dopaminergic neurons in substantia nigra of the central nervous system.